HIV-1 INHIBITS LEISHMANIA-INDUCED CELL-PROLIFERATION BUT NOT PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA

Citation
D. Wolday et al., HIV-1 INHIBITS LEISHMANIA-INDUCED CELL-PROLIFERATION BUT NOT PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA, Scandinavian journal of immunology, 39(4), 1994, pp. 380-386
Citations number
27
Categorie Soggetti
Immunology
ISSN journal
03009475
Volume
39
Issue
4
Year of publication
1994
Pages
380 - 386
Database
ISI
SICI code
0300-9475(1994)39:4<380:HILCBN>2.0.ZU;2-Q
Abstract
The immune response of normal human peripheral blood mononuclear cells (PBMC) after stimulation with human immunodeficiency virus-1 (HIV-1) antigens plus Leishmania donovani promastigotes in vitro was investiga ted. HIV-1-antigen stimulation of PBMC did not induce the intracellula r accumulation of interleukin-6 (IL-6), tumour necrosis factor-alpha ( TNF-alpha), or interferon-gamma (IFN-gamma). However, cells stimulated with L. donovani antigens exhibited the production of IL-6 and TNF-al pha, but not IFN-gamma. Furthermore, co-stimulation of PBMC with HIV-I antigen plus L. donovani resulted in the intracellular accumulation o f IL-6 and TNF-alpha comparable to that of cells that were activated w ith L. donovani antigen alone. Heat-inactivated HIV-1 antigen did not appear to induce or suppress cytokine production by PBMC. However, the same HIV antigens did suppress L. donovani-induced proliferation as w ell as PPD-induced proliferation in a dose-dependent fashion. Elevated levels of serum cytokines have been demonstrated in patients with HIV infection indicating their role in the pathogenesis of HIV-associated immunosuppression. The results may partially support the idea that th e abnormally increased cytokine levels in the sera of HIV-infected sub jects is due to the various opportunistic pathogens that these patient s contract, rather than a response to HIV antigens. As cytokines have been shown to up-regulate HIV replication, the data suggest a role for opportunistic infections in cytokine-induced transactivation of HIV-1 and disease progression.